Scientific Topics

We will provide a clear programme structure by highlighting one special organ system each congress day: heart/cardiovascular, liver and kidney. Above all the congress programme integrates aspects of both basic science and clinical development with a focus on translation and clinical practice.

  • Modelling for cardio­vascular devices Details
  • Apheresis Treatment Details
  • Advances in Biomaterial Details
  • CV Tissue En­gineer­ing I Details
  • Apheresis in Cardio­­vascular Diseases Details
  • Cell Bio­material Inter­action Details
  • Minimal inavasive moni­toring in kidney dialyses Details
  • CV Tissue En­gineer­ing II Details
  • Apheresis in Cardio­vascular Diseases II Details
  • Assessment of Biomaterial Properties Details
  • Extra­corporal Treatment of Sepsis Details
  • CV Stem cells Details
  • Experimentel Apheresis Details
  • Design and Synthesis of Bio­materials Details
  • Pediatric extra­­corporeal perfusion and assist device Details
  • CV Bio­material & Perfusion Details
  • Immune Apheresis Details
  • Immune Apheresis Details
  • Horizon 2020; Future of bio­medical engineer­ing: EU funding Details
  • Liver Support status quo Details
  • Clinical application of cardio­­vascular devices Details
  • Clinical Dialysis I Details
  • Bio­chemical Evalutions Details
  • Liver Support whom to treat Details
  • CV In vivo experiments Details
  • Clinical Dialysis II Details
  • Advances in cardiac regene­ration Details
  • Liver Support - Medical devices Details
  • Industry Symposium "Heart­ware" Details
  • Renal Bio­materials and Device Technology Details
  • Apheresis in Cardio­­vascular Diseases III Details
  • Bio­arti­ficial Liver Support Details
  • IABP and Alter­native Concepts Details
  • Tissue and Organ Engineer­ing Details
  • Apheresis in Trans­­plan­tation & Intensive Care Details
  • Albumin in CRD Details
  • Apheresis and Intensive Care Details
  • Cardiac Devices - Technical Details
  • Special Regula­­tory Session: Biologic devices combi­­nation products Details
  • Working group Uremic Toxins EUTOX Details
  • Cyta­­phere­sis in Inflamma­­tory Bowel Disease Details
  • Working Group Cardio­­vascular Details